Selecta Biosciences Inc.

NASDAQ: SELB · Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM

Selecta Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
212.61M 76.91M 106.44M 114.06M
Short-Term Investments
n/a n/a 28.16M 14M
Long-Term Investments
2M 2M 2M 2M
Other Long-Term Assets
152.79M 151.98M 1.34M 1.47M
Receivables
872K 8.85M 9.76M 9.91M
Inventory
n/a n/a n/a n/a
Other Current Assets
3.14M 4.97M 3.78M 6.47M
Total Current Assets
216.63M 90.73M 148.14M 144.44M
Property-Plant & Equipment
15.45M 12.18M 14.41M 11.97M
Goodwill & Intangibles
48.16M 48.16M n/a n/a
Total Long-Term Assets
218.4M 214.32M 17.75M 15.44M
Total Assets
435.02M 305.05M 165.89M 159.88M
Account Payables
288K 3.15M 316K 224K
Deferred Revenue
n/a 2.31M 593K 53.88M
Short-Term Debt
2.85M 2.17M 10.08M 7.01M
Other Current Liabilities
19.84M 60.58M 14.08M 11.13M
Total Current Liabilities
22.98M 68.21M 25.08M 72.25M
Long-Term Debt
11.13M 8.79M 27.84M 28.27M
Other Long-Term Liabilities
391.57M 348.29M 19.14M 25.42M
Total Long-Term Liabilities
418.85M 376.47M 46.98M 65.11M
Total Liabilities
441.82M 444.68M 72.06M 137.36M
Total Debt
13.98M 10.96M 37.92M 35.28M
Common Stock
3K 16K 15K 12K
Retained Earnings
-692.07M -614.65M -394.94M -430.32M
Comprehensive Income
-4.62M -4.6M -4.56M -4.57M
Shareholders Equity
-6.8M -440.18M 93.83M 22.52M
Total Investments
n/a 2M 30.16M 16M